Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

por Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, H, Agostini, C, Provencal, J, Ferrero, J M, Fric, D, Dohollou, N, Paraiso, D, Salvat, J, Pujade-Lauraine, É
Publicado 2009